bluebird bio, Inc. (BLUE)
NASDAQ: BLUE · Real-Time Price · USD
8.50
-0.73 (-7.91%)
At close: Dec 20, 2024, 4:00 PM
8.39
-0.11 (-1.29%)
After-hours: Dec 20, 2024, 5:59 PM EST
bluebird bio Stock Forecast
BLUE's stock price has decreased by -82.51% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 7 analysts with 12-month price forecasts for bluebird bio stock have an average target of 49.14, with a low estimate of 10 and a high estimate of 120. The average target predicts an increase of 478.12% from the current stock price of 8.50.
Analyst Consensus: Hold
* Price targets were last updated on Nov 15, 2024.
Analyst Ratings
The average analyst rating for bluebird bio stock from 9 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Buy | 4 | 3 | 3 | 3 | 2 | 2 |
| Hold | 5 | 6 | 6 | 6 | 7 | 6 |
| Sell | 2 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 11 | 11 | 11 | 10 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Hold Reiterates $80 | Hold | Reiterates | $80 | +841.18% | Nov 15, 2024 |
| B of A Securities | B of A Securities | Strong Buy → Hold Downgrades $60 → $10 | Strong Buy → Hold | Downgrades | $60 → $10 | +17.65% | Nov 15, 2024 |
| Barclays | Barclays | Buy Maintains $80 → $40 | Buy | Maintains | $80 → $40 | +370.59% | Nov 15, 2024 |
| Wells Fargo | Wells Fargo | Hold Maintains $60 → $40 | Hold | Maintains | $60 → $40 | +370.59% | Sep 25, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Sep 16, 2024 |
Financial Forecast
Revenue This Year
74.54M
from 29.50M
Increased by 152.71%
Revenue Next Year
248.91M
from 74.54M
Increased by 233.91%
EPS This Year
-27.77
from -38.60
EPS Next Year
-8.82
from -27.77
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 91.4M | 403.0M | 434.7M | |||
| Avg | 74.5M | 248.9M | 316.9M | |||
| Low | 62.0M | 147.0M | 239.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 209.7% | 440.6% | 74.6% | |||
| Avg | 152.7% | 233.9% | 27.3% | |||
| Low | 110.3% | 97.2% | -3.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -25.41 | 2.73 | -10.92 | |||
| Avg | -27.77 | -8.82 | -14.48 | |||
| Low | -28.86 | -23.13 | -17.64 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.